Related Experiment Video

Updated: Apr 11, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K

Surprise Questions for Survival Prediction in Patients With Advanced Cancer: A Multicenter Prospective Cohort Study

Jun Hamano1, Tatsuya Morita1, Satoshi Inoue1

  • 1Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan; Palliative and Supportive Care Division, Seirei Mikatahara General Hospital, Hamamatsu, Japan; Seirei Hospice, Seirei Mikatahara General Hospital, Hamamatsu City, Japan; Hospice Children's Hospice Hospital, Yodogawa Christian Hospital, Osaka, Japan; Department of Palliative Medicine, National Cancer Center Hospital East, Kashiwa, Japan; Department of Pain and Palliative Care, Kameda Medical Center, Kamogawa, Japan; Department of Palliative Medicine, Kobe University Graduate School of Medicine, Kobe, Japan; Department of Palliative Care, Mitui Memorial Hospital, Tokyo, Japan; Department of Palliative Medicine, Tohoku University Hospital, Sendai, Japan; Department of Palliative Medicine, Osaka City General Hospital, Osaka, Japan; Komaki City Hospital, Komaki, Japan; Department of Palliative Care Team, and Palliative and Supportive Care, National Kyushu Cancer Center, Fukuoka, Japan; Department of Palliative Care, KKR Sapporo Medical Center, Sapporo, Japan; Department of Psychosomatic Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan; Center for Palliative and Supportive Care, Tsukuba University Hospital, Ibaraki, Japan; Seirei Hamamatsu General Hospital, Hamamatsu, Japan; Department of Primary Care Service, Shinsei Hospital, Nagano, Japan; Saiseikai Matsusaka General Hospital, Matsusaka, Japan; Yuuaikai Nanbu Hospital, Itoman, Japan; Department of Palliative Medicine, National Cancer Center Hospital East, Chiba, Japan.

The Oncologist
|June 10, 2015
PubMed
Abstract

Keywords:
30-day survival7-day survivalAdvanced cancerPrognostic valueSurprise questions

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.1K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

866

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
843
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
748
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
717
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
490
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K